Dutasteride Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with dutasteride
A
- abametapir topical
- AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir)
- AccessPak for HIV PEP Expanded with Viracept (emtricitabine / nelfinavir / tenofovir)
- Accretropin (somatropin)
- Acid Reducer-Cimetidine (cimetidine)
- adagrasib
- Adalat (nifedipine)
- Adalat CC (nifedipine)
- Afeditab CR (nifedipine)
- Agenerase (amprenavir)
- Akynzeo (netupitant / palonosetron)
- Akynzeo for Injection (fosnetupitant / palonosetron)
- Alunbrig (brigatinib)
- amiodarone
- amoxicillin / clarithromycin / lansoprazole
- amoxicillin / clarithromycin / omeprazole
- amoxicillin / clarithromycin / vonoprazan
- amoxicillin / vonoprazan
- amprenavir
- apalutamide
- Aponvie (aprepitant)
- aprepitant
- armodafinil
- asciminib
- Aspruzyo Sprinkle (ranolazine)
- Astagraf XL (tacrolimus)
- atazanavir
- atazanavir / cobicistat
- Atripla (efavirenz / emtricitabine / tenofovir)
- Augtyro (repotrectinib)
- avacopan
More about dutasteride
- dutasteride consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (67)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: 5-alpha-reductase inhibitors
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.